首页 > 最新文献

Learning Health Systems最新文献

英文 中文
Frameworks, guidelines, and tools to develop a learning health system for Indigenous health: An environmental scan for Canada 为土著居民健康发展学习型卫生系统的框架、指南和工具:加拿大环境扫描
IF 3.1 Q2 HEALTH POLICY & SERVICES Pub Date : 2023-07-18 DOI: 10.1002/lrh2.10376
Emma Rice, Angela Mashford-Pringle, Jinfan Qiang, Lynn Henderson, Tammy MacLean, Justin Rhoden, Abigail Simms, Sterling Stutz

Introduction

First Nations, Inuit, and Métis (FNIM) peoples experience systemic health disparities within Ontario's healthcare system. Learning health systems (LHS) is a rapidly growing interdisciplinary area with the potential to address these inequitable health outcomes through a comprehensive health system that draws on science, informatics, incentives, and culture for ongoing innovation and improvement. However, global literature is in its infancy with grounding theories and principles still emerging. In addition, there is inadequate information on LHS within Ontario's health care context.

Methods

We conducted an environmental scan between January and April 2021 and again in June 2022 to identify existing frameworks, guidelines, and tools for designing, developing, implementing, and evaluating an LHS.

Results

We found 37 relevant sources. This paper maps the literature and identifies gaps in knowledge based on five key pillars: (a) data and evidence-driven, (b) patient-centeredness, (c) system-supported, (d) cultural competencies enabled, and (e) the learning health system.

Conclusion

We provide recommendations for implementation accordingly. The literature on LHS provides a starting point to address the health disparities of FNIM peoples within the healthcare system but Indigenous community partnerships in LHS development and operation will be key to success.

导言原住民、因纽特人和梅蒂斯人(FNIM)在安大略省的医疗系统中经历着系统性的健康差异。学习型医疗系统(LHS)是一个快速发展的跨学科领域,有可能通过利用科学、信息学、激励机制和文化进行持续创新和改进的综合医疗系统来解决这些不公平的医疗结果。然而,全球文献尚处于起步阶段,基础理论和原则仍在形成之中。此外,在安大略省的医疗保健背景下,有关 LHS 的信息还不够充分。 方法 我们在 2021 年 1 月至 4 月期间进行了一次环境扫描,并于 2022 年 6 月再次进行扫描,以确定设计、开发、实施和评估 LHS 的现有框架、指南和工具。 结果 我们找到了 37 篇相关资料。本文对文献进行了梳理,并根据以下五大支柱确定了知识差距:(a) 数据和证据驱动;(b) 以患者为中心;(c) 系统支持;(d) 文化能力;(e) 学习型医疗系统。 结论 我们提出了相应的实施建议。关于学习型医疗系统的文献为在医疗系统内解决原住民和土著民族在健康方面的差异提供了一个起点,但原住民社区在学习型医疗系统的发展和运作中的伙伴关系将是成功的关键。
{"title":"Frameworks, guidelines, and tools to develop a learning health system for Indigenous health: An environmental scan for Canada","authors":"Emma Rice,&nbsp;Angela Mashford-Pringle,&nbsp;Jinfan Qiang,&nbsp;Lynn Henderson,&nbsp;Tammy MacLean,&nbsp;Justin Rhoden,&nbsp;Abigail Simms,&nbsp;Sterling Stutz","doi":"10.1002/lrh2.10376","DOIUrl":"10.1002/lrh2.10376","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>First Nations, Inuit, and Métis (FNIM) peoples experience systemic health disparities within Ontario's healthcare system. Learning health systems (LHS) is a rapidly growing interdisciplinary area with the potential to address these inequitable health outcomes through a comprehensive health system that draws on science, informatics, incentives, and culture for ongoing innovation and improvement. However, global literature is in its infancy with grounding theories and principles still emerging. In addition, there is inadequate information on LHS within Ontario's health care context.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted an environmental scan between January and April 2021 and again in June 2022 to identify existing frameworks, guidelines, and tools for designing, developing, implementing, and evaluating an LHS.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>We found 37 relevant sources. This paper maps the literature and identifies gaps in knowledge based on five key pillars: (a) data and evidence-driven, (b) patient-centeredness, (c) system-supported, (d) cultural competencies enabled, and (e) the learning health system.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>We provide recommendations for implementation accordingly. The literature on LHS provides a starting point to address the health disparities of FNIM peoples within the healthcare system but Indigenous community partnerships in LHS development and operation will be key to success.</p>\u0000 </section>\u0000 </div>","PeriodicalId":43916,"journal":{"name":"Learning Health Systems","volume":"8 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2023-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/lrh2.10376","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44196561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Learning healthcare systems in cardiology: A qualitative interview study on ethical dilemmas of a learning healthcare system 心脏病学中的学习医疗系统:关于学习医疗系统伦理困境的定性访谈研究
IF 3.1 Q2 HEALTH POLICY & SERVICES Pub Date : 2023-07-15 DOI: 10.1002/lrh2.10379
Sara Laurijssen, Rieke van der Graaf, Ewoud Schuit, Melina den Haan, Wouter van Dijk, Rolf Groenwold, Saskia le Sessie, Diederick Grobbee, Martine de Vries

Background

Implementation of an LHS in cardiology departments presents itself with ethical challenges, including ethical review and informed consent. In this qualitative study, we investigated stakeholders' attitudes toward ethical issues regarding the implementation of an LHS in the cardiology department.

Methods

We conducted a qualitative study using 35 semi-structured interviews and 5 focus group interviews with 34 individuals. We interviewed cardiologists, research nurses, cardiovascular patients, ethicists, health lawyers, epidemiologists/statisticians and insurance spokespersons.

Results

Respondents identified different ethical obstacles for the implementation of an LHS within the cardiology department. These obstacles were mainly on ethical oversight in LHSs; in particular, informed con sent and data ownership were discussed. In addition, respondents reported on the role of patients in LHS. Respondents described the LHS as a possibility for patients to engage in both research and care. While the LHS can promote patient engagement, patients might also be reduced to their data and are therefore at risk, according to respondents.

Conclusions

Views on the ethical dilemmas of a LHSs within cardiology are diverse. Similar to the literary debate on oversight, there are different views on how ethical oversight should be regulated. This study adds to the literary debate on oversight by highlighting that patients wish to be informed about the learning activities within the LHS they participate in, and that they wish to actively contribute by sharing their data and identifying learning goals, provided that informed consent is obtained.

背景 在心脏科实施 LHS 会面临伦理方面的挑战,包括伦理审查和知情同意。在这项定性研究中,我们调查了利益相关者对心脏科实施 LHS 的伦理问题的态度。 方法 我们对 34 人进行了 35 次半结构化访谈和 5 次焦点小组访谈,从而开展了一项定性研究。我们采访了心脏病专家、研究护士、心血管病患者、伦理学家、健康律师、流行病学家/统计学家和保险发言人。 结果 受访者指出了在心脏科实施 LHS 所面临的不同伦理障碍。这些障碍主要涉及长效医疗系统的伦理监督,尤其是知情同意和数据所有权问题。此外,受访者还报告了患者在 LHS 中的作用。受访者认为长期健康服务为患者参与研究和护理提供了可能。受访者认为,虽然 LHS 可以促进患者的参与,但患者也可能沦为其数据的一部分,因此面临风险。 结论 对心脏病学中的生命健康系统的伦理困境存在不同看法。与文学界关于监督的争论类似,人们对如何规范伦理监督也有不同的看法。本研究为有关监督的文学辩论增添了新的内容,强调了患者希望了解他们所参与的生命健康服务中的学习活动,并希望在获得知情同意的前提下,通过分享自己的数据和确定学习目标来做出积极贡献。
{"title":"Learning healthcare systems in cardiology: A qualitative interview study on ethical dilemmas of a learning healthcare system","authors":"Sara Laurijssen,&nbsp;Rieke van der Graaf,&nbsp;Ewoud Schuit,&nbsp;Melina den Haan,&nbsp;Wouter van Dijk,&nbsp;Rolf Groenwold,&nbsp;Saskia le Sessie,&nbsp;Diederick Grobbee,&nbsp;Martine de Vries","doi":"10.1002/lrh2.10379","DOIUrl":"10.1002/lrh2.10379","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Implementation of an LHS in cardiology departments presents itself with ethical challenges, including ethical review and informed consent. In this qualitative study, we investigated stakeholders' attitudes toward ethical issues regarding the implementation of an LHS in the cardiology department.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted a qualitative study using 35 semi-structured interviews and 5 focus group interviews with 34 individuals. We interviewed cardiologists, research nurses, cardiovascular patients, ethicists, health lawyers, epidemiologists/statisticians and insurance spokespersons.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Respondents identified different ethical obstacles for the implementation of an LHS within the cardiology department. These obstacles were mainly on ethical oversight in LHSs; in particular, informed con sent and data ownership were discussed. In addition, respondents reported on the role of patients in LHS. Respondents described the LHS as a possibility for patients to engage in both research and care. While the LHS can promote patient engagement, patients might also be reduced to their data and are therefore at risk, according to respondents.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Views on the ethical dilemmas of a LHSs within cardiology are diverse. Similar to the literary debate on oversight, there are different views on how ethical oversight should be regulated. This study adds to the literary debate on oversight by highlighting that patients wish to be informed about the learning activities within the LHS they participate in, and that they wish to actively contribute by sharing their data and identifying learning goals, provided that informed consent is obtained.</p>\u0000 </section>\u0000 </div>","PeriodicalId":43916,"journal":{"name":"Learning Health Systems","volume":"8 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2023-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/lrh2.10379","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44253121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Learning health system benefits: Development and initial validation of a framework 了解卫生系统的益处:框架的开发和初步验证
IF 3.1 Q2 HEALTH POLICY & SERVICES Pub Date : 2023-07-11 DOI: 10.1002/lrh2.10380
Lisa C. Welch, Sarah K. Brewer, Titus Schleyer, Denise Daudelin, Rechelle Paranal, Joe D. Hunt, Ann M. Dozier, Anna Perry, Alyssa B. Cabrera, Cheryl L. Gatto

Introduction

Implementation of research findings in clinical practice often is not realized or only partially achieved, and if so, with a significant delay. Learning health systems (LHSs) hold promise to overcome this problem by embedding clinical research and evidence-based best practices into care delivery, enabling innovation and continuous improvement. Implementing an LHS is a complex process that requires participation and resources of a wide range of stakeholders, including healthcare leaders, clinical providers, patients and families, payers, and researchers. Engaging these stakeholders requires communicating clear, tangible value propositions. Existing models identify broad categories of benefits but do not explicate the full range of benefits or ways they can manifest in different organizations.

Methods

To develop such a framework, a working group with representatives from six Clinical and Translational Science Award (CTSA) hubs reviewed existing literature on LHS characteristics, models, and goals; solicited expert input; and applied the framework to their local LHS experiences.

Results

The Framework of LHS Benefits includes six categories of benefits (quality, safety, equity, patient satisfaction, reputation, and value) relevant for a range of stakeholders and defines key concepts within each benefit. Applying the framework to five LHS case examples indicated preliminary face validity across varied LHS approaches and revealed three dimensions in which the framework is relevant: defining goals of individual LHS projects, facilitating collaboration based on shared values, and establishing guiding tenets of an LHS program or mission.

Conclusion

The framework can be used to communicate the value of an LHS to different stakeholders across varied contexts and purposes, and to identify future organizational priorities. Further validation will contribute to the framework's evolution and support its potential to inform the development of tools to evaluate LHS impact.

引言 在临床实践中,研究成果的实施往往无法实现或只能部分实现,即使实现了,也会严重滞后。学习型医疗系统(LHS)将临床研究和循证最佳实践融入医疗服务中,促进创新和持续改进,有望解决这一问题。实施学习型医疗系统是一个复杂的过程,需要广泛的利益相关者的参与和资源,其中包括医疗保健领导者、临床服务提供者、患者和家属、支付者以及研究人员。要让这些利益相关者参与进来,就需要传达明确、切实的价值主张。现有的模型确定了广泛的效益类别,但并没有说明各种效益或它们在不同组织中的表现形式。 方法 为了制定这样一个框架,一个由来自六个临床与转化科学奖(CTSA)中心的代表组成的工作组回顾了有关长效机制特点、模式和目标的现有文献;征求了专家的意见;并将该框架应用到他们当地的长效机制经验中。 结果 长效医疗系统效益框架包括与一系列利益相关者相关的六类效益(质量、安全、公平、患者满意度、声誉和价值),并定义了每类效益中的关键概念。将该框架应用于五个长者健康服务案例表明,该框架在不同的长者健康服务方法中具有初步的表面有效性,并揭示了该框架的三个相关方面:确定个别长者健康服务项目的目标、促进基于共同价值观的合作,以及确立长者健康服务计划或使命的指导原则。 结论 该框架可用于向不同背景和目的的利益相关者宣传长者健康服务的价值,并确定未来组织的优先事项。进一步的验证将有助于该框架的发展,并支持其为开发评估长者健康服务影响的工具提供信息的潜力。
{"title":"Learning health system benefits: Development and initial validation of a framework","authors":"Lisa C. Welch,&nbsp;Sarah K. Brewer,&nbsp;Titus Schleyer,&nbsp;Denise Daudelin,&nbsp;Rechelle Paranal,&nbsp;Joe D. Hunt,&nbsp;Ann M. Dozier,&nbsp;Anna Perry,&nbsp;Alyssa B. Cabrera,&nbsp;Cheryl L. Gatto","doi":"10.1002/lrh2.10380","DOIUrl":"10.1002/lrh2.10380","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Implementation of research findings in clinical practice often is not realized or only partially achieved, and if so, with a significant delay. Learning health systems (LHSs) hold promise to overcome this problem by embedding clinical research and evidence-based best practices into care delivery, enabling innovation and continuous improvement. Implementing an LHS is a complex process that requires participation and resources of a wide range of stakeholders, including healthcare leaders, clinical providers, patients and families, payers, and researchers. Engaging these stakeholders requires communicating clear, tangible value propositions. Existing models identify broad categories of benefits but do not explicate the full range of benefits or ways they can manifest in different organizations.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>To develop such a framework, a working group with representatives from six Clinical and Translational Science Award (CTSA) hubs reviewed existing literature on LHS characteristics, models, and goals; solicited expert input; and applied the framework to their local LHS experiences.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The Framework of LHS Benefits includes six categories of benefits (quality, safety, equity, patient satisfaction, reputation, and value) relevant for a range of stakeholders and defines key concepts within each benefit. Applying the framework to five LHS case examples indicated preliminary face validity across varied LHS approaches and revealed three dimensions in which the framework is relevant: defining goals of individual LHS projects, facilitating collaboration based on shared values, and establishing guiding tenets of an LHS program or mission.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The framework can be used to communicate the value of an LHS to different stakeholders across varied contexts and purposes, and to identify future organizational priorities. Further validation will contribute to the framework's evolution and support its potential to inform the development of tools to evaluate LHS impact.</p>\u0000 </section>\u0000 </div>","PeriodicalId":43916,"journal":{"name":"Learning Health Systems","volume":"8 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2023-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/lrh2.10380","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46379491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MCBK 2022 Lightning Round Abstracts MCBK 2022闪电轮摘要
IF 3.1 Q2 HEALTH POLICY & SERVICES Pub Date : 2023-07-03 DOI: 10.1002/lrh2.10375
<p>Brian S. Alper, Computable Publishing LLC, Scientific Knowledge Accelerator Foundation. <span>[email protected]</span></p><p>Joanne Dehnbostel, Computable Publishing LLC, Scientific Knowledge Accelerator Foundation. <span>[email protected]</span></p><p>Khalid Shahin Computable Publishing LLC, Scientific Knowledge Accelerator Foundation. <span>[email protected]</span></p><p>Fast Healthcare Interoperability Resources (FHIR) is a standard describing data formats for exchanging electronic health records. FHIR is highly effective for mobilization of patient-specific computable healthcare knowledge, but similar solutions have not been developed for community knowledge such scientific research and clinical practice guidance, until now.</p><p>Extension of FHIR to Evidence-Based Medicine (EBMonFHIR) is providing a standard to mobilize evidence and guidance. FHIR Resources have been created for exchange of Citation, Evidence, EvidenceVariable, EvidenceReport, ResearchStudy, and ArtifactAssessment (to provide comments, ratings and classifiers for any other knowledge artifact). The Fast EVIDENCE Interoperability Resources (FEvIR) Platform is freely available at https://fevir.net and supports the creation and viewing of computable biomedical knowledge in standard form, using FHIR JSON where specified and FHIR-like JSON where needed as we further develop the FHIR standard. Resources (in FHIR R5 JSON) currently on the FEvIR Platform include ActivityDefinition, ArtifactAssessment, Bundle, Citation, CodeSystem, Consent, Evidence, EvidenceReport, EvidenceVariable, Group, Organization, Practitioner, PractitionerRole, Questionnaire, ResearchStudy, ResearchSubject, StructureDefinition, and ValueSet.</p><p>The FEvIR Platform is open for viewing resources without login or registration. Signing in is free, as simple as using Google account login, and is required to create content on the FEvIR Platform as the person who creates the content is the only one with edit rights to that content.</p><p>The FEvIR Platform has 13 Viewer Tools that provide human-friendly displays of FHIR Resources that include outline representation of the JSON and/or specialized views based on the resource type. The FEvIR Platform has eight builder tools that enable creation of a FHIR Resource without any working knowledge of FHIR or JSON.</p><p>The FEvIR Platform has three Converter Tools (MEDLINE-to-FEvIR, ClinicalTrials.gov-to-FEvIR, and FEvIR-to-ClinicalTrials.gov) that facilitate interoperable data exchange between systems.</p><p>The FEvIR Platform has five Specialized Tools (My Ballot, Portal View, Recommendations Table Viewer, Risk of Bias Assessment Tool, and Risk of Bias Assessment Reader) for organized creation and viewing across resources in context-relevant combinations.</p><p>The FEvIR Platform is used to support the COVID-19 Knowledge Accelerator (COKA). COKA is an open, virtual group to accelerate identifying, processing, and disseminating knowledge (about COVID-19 but could be a
这个
{"title":"MCBK 2022 Lightning Round Abstracts","authors":"","doi":"10.1002/lrh2.10375","DOIUrl":"10.1002/lrh2.10375","url":null,"abstract":"&lt;p&gt;Brian S. Alper, Computable Publishing LLC, Scientific Knowledge Accelerator Foundation. &lt;span&gt;[email protected]&lt;/span&gt;&lt;/p&gt;&lt;p&gt;Joanne Dehnbostel, Computable Publishing LLC, Scientific Knowledge Accelerator Foundation. &lt;span&gt;[email protected]&lt;/span&gt;&lt;/p&gt;&lt;p&gt;Khalid Shahin Computable Publishing LLC, Scientific Knowledge Accelerator Foundation. &lt;span&gt;[email protected]&lt;/span&gt;&lt;/p&gt;&lt;p&gt;Fast Healthcare Interoperability Resources (FHIR) is a standard describing data formats for exchanging electronic health records. FHIR is highly effective for mobilization of patient-specific computable healthcare knowledge, but similar solutions have not been developed for community knowledge such scientific research and clinical practice guidance, until now.&lt;/p&gt;&lt;p&gt;Extension of FHIR to Evidence-Based Medicine (EBMonFHIR) is providing a standard to mobilize evidence and guidance. FHIR Resources have been created for exchange of Citation, Evidence, EvidenceVariable, EvidenceReport, ResearchStudy, and ArtifactAssessment (to provide comments, ratings and classifiers for any other knowledge artifact). The Fast EVIDENCE Interoperability Resources (FEvIR) Platform is freely available at https://fevir.net and supports the creation and viewing of computable biomedical knowledge in standard form, using FHIR JSON where specified and FHIR-like JSON where needed as we further develop the FHIR standard. Resources (in FHIR R5 JSON) currently on the FEvIR Platform include ActivityDefinition, ArtifactAssessment, Bundle, Citation, CodeSystem, Consent, Evidence, EvidenceReport, EvidenceVariable, Group, Organization, Practitioner, PractitionerRole, Questionnaire, ResearchStudy, ResearchSubject, StructureDefinition, and ValueSet.&lt;/p&gt;&lt;p&gt;The FEvIR Platform is open for viewing resources without login or registration. Signing in is free, as simple as using Google account login, and is required to create content on the FEvIR Platform as the person who creates the content is the only one with edit rights to that content.&lt;/p&gt;&lt;p&gt;The FEvIR Platform has 13 Viewer Tools that provide human-friendly displays of FHIR Resources that include outline representation of the JSON and/or specialized views based on the resource type. The FEvIR Platform has eight builder tools that enable creation of a FHIR Resource without any working knowledge of FHIR or JSON.&lt;/p&gt;&lt;p&gt;The FEvIR Platform has three Converter Tools (MEDLINE-to-FEvIR, ClinicalTrials.gov-to-FEvIR, and FEvIR-to-ClinicalTrials.gov) that facilitate interoperable data exchange between systems.&lt;/p&gt;&lt;p&gt;The FEvIR Platform has five Specialized Tools (My Ballot, Portal View, Recommendations Table Viewer, Risk of Bias Assessment Tool, and Risk of Bias Assessment Reader) for organized creation and viewing across resources in context-relevant combinations.&lt;/p&gt;&lt;p&gt;The FEvIR Platform is used to support the COVID-19 Knowledge Accelerator (COKA). COKA is an open, virtual group to accelerate identifying, processing, and disseminating knowledge (about COVID-19 but could be a","PeriodicalId":43916,"journal":{"name":"Learning Health Systems","volume":"7 3","pages":""},"PeriodicalIF":3.1,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/lrh2.10375","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45603664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conceptualizing and redefining successful patient engagement in patient advisory councils in learning health networks 概念化和重新定义学习健康网络中患者咨询委员会中成功的患者参与
IF 3.1 Q2 HEALTH POLICY & SERVICES Pub Date : 2023-06-20 DOI: 10.1002/lrh2.10377
Madeleine Huwe, Becky Woolf, Jennie David, Michael Seid, Shehzad Saeed, Peter Margolis, ImproveCareNow Pediatric IBD Learning Health System

Introduction

Patient engagement has historically referenced engagement in one's healthcare, with more recent definitions expanding patient engagement to encompass patient advocacy work in Learning Health Networks (LHNs). Efforts to conceptualize and define what patient engagement means—and what successful patient engagement means—are, however, lacking and a barrier to meaningful and sustainable patient engagement via patient advisory councils (PACs) across LHNs.

Methods

Several co-authors (Madeleine Huwe, Becky Woolf, Jennie David) are former ImproveCareNow (ICN) PAC members, and we integrate a narrative review of the extant literature and a case study of our lived experiences as former ICN PAC members. We present nuanced themes of successful patient engagement from our lived experiences on ICN's PAC, with illustrative quotes from other PAC members, and then propose themes and metrics to consider in patient engagement across LHNs.

Results

Successful patient engagement in our experiences with ICN's PAC reaches beyond the “levels of engagement” previously described in the literature. We posit that our successful patient/PAC engagement experiences with ICN represent key mechanisms that could be applied across LHNs, including (1) personal growth for PAC members, (2) PAC internal engagement/community, (3) PAC engagement and presence within the LHN, (4) local institutional engagement for those who participate in the LHN, and (5) tangible resources/products from PAC members.

Conclusion

Patient engagement in LHNs, like ICN, holds significant power to meaningfully shape and co-produce healthcare systems, and engagement is undervalued and conceptualized dichotomously (eg, engaged or not engaged). Reconceptualizing successful patient/PAC engagement is critical in ongoing efforts to study, support, and understand mechanisms of sustainable and successful patient engagement. Having a modern, multidimensional definition for successful patient engagement in LHNs can support efforts to increase underrepresented voices in PACs, measure and track successful multidimensional patient engagement, and study how successful patient engagement may impact outcomes for patients and LHNs.

导言:患者参与历来指的是参与个人的医疗保健,最近的定义将患者参与扩展到包括学习型医疗网络(LHNs)中的患者宣传工作。然而,目前还缺乏对患者参与的含义--以及成功的患者参与的含义--进行概念化和定义的努力,这也是通过患者咨询委员会(PACs)在LHNs中开展有意义和可持续的患者参与的障碍。 方法 几位共同作者(Madeleine Huwe、Becky Woolf、Jennie David)都曾是 "现在改善医疗"(ICN)患者咨询委员会(PAC)的成员,我们将对现有文献的叙述性回顾与我们作为前 ICN PAC 成员的亲身经历的案例研究相结合。我们从自己在 ICN PAC 的亲身经历中提出了患者成功参与的细微主题,并引用了其他 PAC 成员的例证,然后提出了 LHN 患者参与的主题和衡量标准。 结果 在我们与 ICN 患者咨询委员会合作的经历中,患者的成功参与超出了以往文献中描述的 "参与程度"。我们认为,我们在 ICN 的患者/PAC 成功参与经验代表了可应用于所有 LHN 的关键机制,包括:(1)PAC 成员的个人成长;(2)PAC 内部参与/社区;(3)PAC 在 LHN 中的参与和存在;(4)参与 LHN 的当地机构参与;以及(5)PAC 成员提供的有形资源/产品。 结论 患者在 LHN 中的参与,如 ICN,对有意义地塑造和共同生产医疗保健系统具有重要作用,但参与的价值被低估,并被二分法概念化(如参与或不参与)。重新定义患者/PAC 成功参与的概念对于研究、支持和了解患者可持续成功参与的机制至关重要。为患者在 LHN 中的成功参与制定一个现代的、多维度的定义,可以支持增加 PAC 中代表性不足的声音、衡量和跟踪成功的多维度患者参与,以及研究成功的患者参与如何影响患者和 LHN 的结果。
{"title":"Conceptualizing and redefining successful patient engagement in patient advisory councils in learning health networks","authors":"Madeleine Huwe,&nbsp;Becky Woolf,&nbsp;Jennie David,&nbsp;Michael Seid,&nbsp;Shehzad Saeed,&nbsp;Peter Margolis,&nbsp;ImproveCareNow Pediatric IBD Learning Health System","doi":"10.1002/lrh2.10377","DOIUrl":"10.1002/lrh2.10377","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Patient engagement has historically referenced engagement in one's healthcare, with more recent definitions expanding patient engagement to encompass patient advocacy work in Learning Health Networks (LHNs). Efforts to conceptualize and define what patient engagement means—and what <i>successful</i> patient engagement means—are, however, lacking and a barrier to meaningful and sustainable patient engagement via patient advisory councils (PACs) across LHNs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Several co-authors (Madeleine Huwe, Becky Woolf, Jennie David) are former ImproveCareNow (ICN) PAC members, and we integrate a narrative review of the extant literature and a case study of our lived experiences as former ICN PAC members. We present nuanced themes of successful patient engagement from our lived experiences on ICN's PAC, with illustrative quotes from other PAC members, and then propose themes and metrics to consider in patient engagement across LHNs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Successful patient engagement in our experiences with ICN's PAC reaches beyond the “levels of engagement” previously described in the literature. We posit that our successful patient/PAC engagement experiences with ICN represent key mechanisms that could be applied across LHNs, including (1) personal growth for PAC members, (2) PAC internal engagement/community, (3) PAC engagement and presence within the LHN, (4) local institutional engagement for those who participate in the LHN, and (5) tangible resources/products from PAC members.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Patient engagement in LHNs, like ICN, holds significant power to meaningfully shape and co-produce healthcare systems, and engagement is undervalued and conceptualized dichotomously (eg, engaged or not engaged). Reconceptualizing successful patient/PAC engagement is critical in ongoing efforts to study, support, and understand mechanisms of sustainable and successful patient engagement. Having a modern, multidimensional definition for successful patient engagement in LHNs can support efforts to increase underrepresented voices in PACs, measure and track successful multidimensional patient engagement, and study how successful patient engagement may impact outcomes for patients and LHNs.</p>\u0000 </section>\u0000 </div>","PeriodicalId":43916,"journal":{"name":"Learning Health Systems","volume":"8 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/lrh2.10377","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42366018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can we identify the prevalence of perinatal mental health using routinely collected health data?: A review of publicly available perinatal mental health data sources in England 我们能否利用常规收集的健康数据确定围产期心理健康的患病率?对英国公开的围产期心理健康数据来源的审查
IF 3.1 Q2 HEALTH POLICY & SERVICES Pub Date : 2023-06-19 DOI: 10.1002/lrh2.10374
Sarah Masefield, Kathryn Willan, Zoe Darwin, Sarah Blower, Chandani Nekitsing, Josie Dickerson

Introduction

Perinatal mental health (PMH) conditions affect around one in four women, and may be even higher in women from some ethnic minority groups and those living in low socioeconomic circumstances. Poor PMH causes significant distress and can have lifelong adverse impacts for some children. In England, current prevalence rates are estimated using mental health data of the general population and do not take sociodemographic variance of geographical areas into account. Services cannot plan their capacity and ensure appropriate and timely support using these estimates. Our aim was to see if PMH prevalence rates could be identified using existing publicly available sources of routine health data.

Methods

A review of data sources was completed by searching NHS Digital (now NHS England), Public Health England and other national PMH resources, performing keyword searches online, and research team knowledge of the field. The sources were screened for routine data that could be used to produce prevalence of PMH conditions by sociodemographic variation. Included sources were reviewed for their utility in accessibility, data relevance and technical specification relating to PMH and sociodemographic data items.

Results

We found a PMH data ‘blind spot’ with significant inadequacies in the utility of all identified data sources, making it impossible to provide information on the prevalence of PMH in England and understand variation by sociodemographic differences.

Conclusions

To enhance the utility of publicly available routine data to provide PMH prevalence rates requires improved mandatory PMH data capture in universal services, available publicly via one platform and including assessment outcomes and sociodemographic data.

导言 围产期心理健康(PMH)状况影响着大约四分之一的妇女,在一些少数民族群体和社会经济条件较差的妇女中,这一比例可能更高。不良的围产期精神健康状况会造成极大的困扰,并可能对某些儿童产生终生的不良影响。在英格兰,目前的患病率是根据普通人群的心理健康数据估算的,并没有考虑到地理区域的社会人口差异。服务机构无法根据这些估计值来规划其服务能力,并确保提供适当、及时的支持。我们的目的是研究能否利用现有的公开的常规健康数据来源来确定 PMH 患病率。 方法 通过搜索英国国家医疗服务系统(NHS Digital)(现为英国国家医疗服务系统)、英国公共卫生部门及其他国家 PMH 资源、在线执行关键字搜索以及研究团队对该领域的了解,完成了对数据来源的审查。研究人员对资料来源进行了筛选,以确定是否有常规数据可用于按社会人口统计学差异计算 PMH 发病率。我们对所纳入的资料来源进行了审查,以确定其在可访问性、数据相关性以及与 PMH 和社会人口学数据项有关的技术规范方面的实用性。 结果 我们发现了一个 PMH 数据 "盲点",所有已确定的数据源在实用性方面都存在明显不足,因此无法提供有关英格兰 PMH 患病率的信息,也无法了解社会人口学差异带来的变化。 结论 要提高公开常规数据的效用,以提供 PMH 患病率,就需要改进普遍服务中的强制性 PMH 数据采集,通过一个平台公开提供,并包括评估结果和社会人口学数据。
{"title":"Can we identify the prevalence of perinatal mental health using routinely collected health data?: A review of publicly available perinatal mental health data sources in England","authors":"Sarah Masefield,&nbsp;Kathryn Willan,&nbsp;Zoe Darwin,&nbsp;Sarah Blower,&nbsp;Chandani Nekitsing,&nbsp;Josie Dickerson","doi":"10.1002/lrh2.10374","DOIUrl":"10.1002/lrh2.10374","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Perinatal mental health (PMH) conditions affect around one in four women, and may be even higher in women from some ethnic minority groups and those living in low socioeconomic circumstances. Poor PMH causes significant distress and can have lifelong adverse impacts for some children. In England, current prevalence rates are estimated using mental health data of the general population and do not take sociodemographic variance of geographical areas into account. Services cannot plan their capacity and ensure appropriate and timely support using these estimates. Our aim was to see if PMH prevalence rates could be identified using existing publicly available sources of routine health data.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A review of data sources was completed by searching NHS Digital (now NHS England), Public Health England and other national PMH resources, performing keyword searches online, and research team knowledge of the field. The sources were screened for routine data that could be used to produce prevalence of PMH conditions by sociodemographic variation. Included sources were reviewed for their utility in accessibility, data relevance and technical specification relating to PMH and sociodemographic data items.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>We found a PMH data ‘blind spot’ with significant inadequacies in the utility of all identified data sources, making it impossible to provide information on the prevalence of PMH in England and understand variation by sociodemographic differences.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>To enhance the utility of publicly available routine data to provide PMH prevalence rates requires improved mandatory PMH data capture in universal services, available publicly via one platform and including assessment outcomes and sociodemographic data.</p>\u0000 </section>\u0000 </div>","PeriodicalId":43916,"journal":{"name":"Learning Health Systems","volume":"8 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2023-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/lrh2.10374","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47909155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Developing LHS scholars’ competency around reducing burnout and moral injury 围绕减少倦怠和道德伤害培养LHS学者的能力
IF 3.1 Q2 HEALTH POLICY & SERVICES Pub Date : 2023-06-18 DOI: 10.1002/lrh2.10378
Sirin Yilmaz, Michele LeClaire, Abbie Begnaud, Warren McKinney, Kasey R. Boehmer, Cory Schaffhausen, Mark Linzer

Despite the known benefits of supportive work environments for promoting patient quality and safety and healthcare worker retention, there is no clear mandate for improving work environments within Learning Health Systems (LHS) nor an LHS wellness competency. Striking rises in burnout levels among healthcare workers provide urgency for this topic.

Methods

We brought three experts on moral injury, burnout prevention, and ethics to a recurring, interactive LHS training program “Design Shop” session, harnessing scholars’ ideas prior to the meeting. Generally following SQUIRE 2.0 guidelines, we evaluated the prework and discussion via informal content analysis to develop a set of pathways for developing moral injury and burnout prevention programs. Along these lines, we developed a new competency for moral injury and burnout prevention within LHS training programs.

Results

In preparation for the session, scholars differentiated moral injury from burnout, highlighted the profound impact of COVID-19 on moral injury, and proposed testable interventions to reduce injury. Scholar and expert input was then merged into developing the new competency in moral injury and burnout prevention. In particular, the competency focuses on preparing scholars to (1) demonstrate knowledge of moral injury and burnout, (2) measure burnout, moral injury, and their remediable predictors, (3) use methods for improving burnout, (4) structure training programs with supportive work environments, and (5) embed burnout and moral injury prevention into LHS structures.

Conclusions

Burnout and moral injury prevention have been largely omitted in LHS training. A competency related to burnout and moral injury reduction can potentially bring sustainable work lives for scholars and their colleagues, better incorporation of their science into clinical practice, and better outcomes for patients.

尽管众所周知,支持性工作环境对提高患者质量和安全以及留住医护人员大有裨益,但在学习型医疗系统(LHS)中,并没有改善工作环境的明确规定,也没有学习型医疗系统的健康能力。医护人员职业倦怠水平的显著上升为这一课题的研究提供了紧迫性。 方法 我们邀请了三位道德伤害、职业倦怠预防和伦理学方面的专家参加一个经常性、互动性的 LHS 培训项目 "设计车间 "会议,在会前利用学者们的想法。一般来说,我们遵循 SQUIRE 2.0 准则,通过非正式内容分析对前期工作和讨论进行评估,从而制定出一套道德伤害和职业倦怠预防计划的开发路径。根据这些方法,我们在地方保健服务培训项目中开发了一种新的预防道德伤害和职业倦怠的能力。 结果 在会议准备过程中,学者们区分了道德伤害与职业倦怠,强调了 COVID-19 对道德伤害的深远影响,并提出了减少伤害的可检验干预措施。随后,学者和专家的意见被整合到新的道德伤害和职业倦怠预防能力的开发中。尤其是,该能力重点培养学者们(1)展示道德伤害和职业倦怠的知识,(2)测量职业倦怠、道德伤害及其可补救的预测因素,(3)使用改善职业倦怠的方法,(4)构建具有支持性工作环境的培训计划,以及(5)将职业倦怠和道德伤害预防纳入地方保健系统结构。 结论 职业倦怠和精神伤害预防在本地保健服务培训中被忽略了。与减少职业倦怠和道德伤害相关的能力有可能为学者及其同事带来可持续的工作生活,将他们的科学更好地融入临床实践,并为患者带来更好的治疗效果。
{"title":"Developing LHS scholars’ competency around reducing burnout and moral injury","authors":"Sirin Yilmaz,&nbsp;Michele LeClaire,&nbsp;Abbie Begnaud,&nbsp;Warren McKinney,&nbsp;Kasey R. Boehmer,&nbsp;Cory Schaffhausen,&nbsp;Mark Linzer","doi":"10.1002/lrh2.10378","DOIUrl":"10.1002/lrh2.10378","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <p>Despite the known benefits of supportive work environments for promoting patient quality and safety and healthcare worker retention, there is no clear mandate for improving work environments within Learning Health Systems (LHS) nor an LHS wellness competency. Striking rises in burnout levels among healthcare workers provide urgency for this topic.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We brought three experts on moral injury, burnout prevention, and ethics to a recurring, interactive LHS training program “Design Shop” session, harnessing scholars’ ideas prior to the meeting. Generally following SQUIRE 2.0 guidelines, we evaluated the prework and discussion via informal content analysis to develop a set of pathways for developing moral injury and burnout prevention programs. Along these lines, we developed a new competency for moral injury and burnout prevention within LHS training programs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>In preparation for the session, scholars differentiated moral injury from burnout, highlighted the profound impact of COVID-19 on moral injury, and proposed testable interventions to reduce injury. Scholar and expert input was then merged into developing the new competency in moral injury and burnout prevention. In particular, the competency focuses on preparing scholars to (1) demonstrate knowledge of moral injury and burnout, (2) measure burnout, moral injury, and their remediable predictors, (3) use methods for improving burnout, (4) structure training programs with supportive work environments, and (5) embed burnout and moral injury prevention into LHS structures.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Burnout and moral injury prevention have been largely omitted in LHS training. A competency related to burnout and moral injury reduction can potentially bring sustainable work lives for scholars and their colleagues, better incorporation of their science into clinical practice, and better outcomes for patients.</p>\u0000 </section>\u0000 </div>","PeriodicalId":43916,"journal":{"name":"Learning Health Systems","volume":"8 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2023-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/lrh2.10378","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49661239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stakeholder perspectives on data sharing from pragmatic clinical trials: Unanticipated challenges for meeting emerging requirements 利益相关者对务实临床试验数据共享的看法:满足新需求的意外挑战
IF 3.1 Q2 HEALTH POLICY & SERVICES Pub Date : 2023-05-01 DOI: 10.1002/lrh2.10366
Stephanie R. Morain, Juli Bollinger, Kevin Weinfurt, Jeremy Sugarman

Introduction

Numerous arguments have been advanced for broadly sharing de-identified, participant-level clinical trial data. However, data sharing in pragmatic clinical trials (PCTs) presents ethical challenges. While prior scholarship has described aspects of PCTs that raise distinct considerations for data sharing, there have been no reports of the experiences of those at the leading edge of data-sharing efforts for PCTs, including how these particular challenges have been navigated. To address this gap, we conducted interviews with key stakeholders, with a focus on the ethical issues presented by sharing data from PCTs.

Methods

We recruited respondents using purposive sampling to reflect the range of stakeholder groups affected by efforts to expand PCT data sharing. Through semi-structured interviews, we explored respondents' experiences and perceptions about sharing de-identified, individual-level data from PCTs. An integrated approach was used to identify and describe key themes.

Results

We conducted 40 interviews between April and September 2022. Five overarching themes emerged through analysis: (1) challenges in sharing data collected under a waiver or alteration of consent; (2) conflicting views regarding PCT patient-subject preferences for data sharing; (3) identification of respect-promoting practices beyond consent; (4) concerns about elevated risks or burdens from sharing PCT data; and (5) diverse views about the likely benefits resulting from sharing PCT data.

Conclusion

Our data indicate unresolved tensions in how to fulfill the expectation to broadly share de-identified, individual-level data from PCTs, and suggest that those promulgating and implementing data-sharing policies must be sensitive to PCT-specific considerations. Future work could inform efforts to tailor data-sharing policy and practice to reflect the challenges presented by PCTs, including sharing experiences from trials that have successfully navigated these tensions.

导言:对于广泛共享去标识化、参与者水平的临床试验数据,人们提出了许多论据。然而,实用临床试验(PCT)中的数据共享面临着伦理挑战。虽然之前的学术研究已经描述了 PCT 在数据共享方面需要特别考虑的方面,但还没有关于处于 PCT 数据共享工作前沿的人员的经验,包括如何应对这些特殊挑战的报告。为了填补这一空白,我们对主要利益相关者进行了访谈,重点关注 PCT 数据共享带来的伦理问题。 方法 我们采用目的性抽样的方式招募受访者,以反映受扩大 PCT 数据共享工作影响的利益相关者群体的范围。通过半结构式访谈,我们探究了受访者对于共享来自 PCT 的去标识化个人层面数据的经验和看法。我们采用了一种综合方法来识别和描述关键主题。 结果 我们在 2022 年 4 月至 9 月期间进行了 40 次访谈。通过分析,我们发现了五大主题:(1) 分享在放弃或更改同意书的情况下收集的数据所面临的挑战;(2) 关于 PCT 患者-受试者数据共享偏好的意见冲突;(3) 识别同意书之外的促进尊重的做法;(4) 担心分享 PCT 数据会增加风险或负担;(5) 对分享 PCT 数据可能带来的益处有不同看法。 结论 我们的数据表明,在如何实现广泛共享来自 PCT 的去标识化个人层面数据的期望方面,存在着尚未解决的矛盾,并表明颁布和实施数据共享政策者必须对 PCT 的具体考虑因素保持敏感。未来的工作可以为调整数据共享政策和实践提供信息,以反映PCT带来的挑战,包括分享成功应对这些矛盾的试验经验。
{"title":"Stakeholder perspectives on data sharing from pragmatic clinical trials: Unanticipated challenges for meeting emerging requirements","authors":"Stephanie R. Morain,&nbsp;Juli Bollinger,&nbsp;Kevin Weinfurt,&nbsp;Jeremy Sugarman","doi":"10.1002/lrh2.10366","DOIUrl":"10.1002/lrh2.10366","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Numerous arguments have been advanced for broadly sharing de-identified, participant-level clinical trial data. However, data sharing in pragmatic clinical trials (PCTs) presents ethical challenges. While prior scholarship has described aspects of PCTs that raise distinct considerations for data sharing, there have been no reports of the experiences of those at the leading edge of data-sharing efforts for PCTs, including how these particular challenges have been navigated. To address this gap, we conducted interviews with key stakeholders, with a focus on the ethical issues presented by sharing data from PCTs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We recruited respondents using purposive sampling to reflect the range of stakeholder groups affected by efforts to expand PCT data sharing. Through semi-structured interviews, we explored respondents' experiences and perceptions about sharing de-identified, individual-level data from PCTs. An integrated approach was used to identify and describe key themes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>We conducted 40 interviews between April and September 2022. Five overarching themes emerged through analysis: (1) challenges in sharing data collected under a waiver or alteration of consent; (2) conflicting views regarding PCT patient-subject preferences for data sharing; (3) identification of respect-promoting practices beyond consent; (4) concerns about elevated risks or burdens from sharing PCT data; and (5) diverse views about the likely benefits resulting from sharing PCT data.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Our data indicate unresolved tensions in how to fulfill the expectation to broadly share de-identified, individual-level data from PCTs, and suggest that those promulgating and implementing data-sharing policies must be sensitive to PCT-specific considerations. Future work could inform efforts to tailor data-sharing policy and practice to reflect the challenges presented by PCTs, including sharing experiences from trials that have successfully navigated these tensions.</p>\u0000 </section>\u0000 </div>","PeriodicalId":43916,"journal":{"name":"Learning Health Systems","volume":"8 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/lrh2.10366","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49496201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Striking a match between FHIR-based patient data and FHIR-based eligibility criteria 在基于FHIR的患者数据和基于FHIR的资格标准之间进行匹配
IF 3.1 Q2 HEALTH POLICY & SERVICES Pub Date : 2023-04-18 DOI: 10.1002/lrh2.10368
Brian S. Alper, Joanne Dehnbostel, Khalid Shahin, Neeraj Ojha, Gopal Khanna, Christopher J. Tignanelli

Inputs and Outputs

The Strike-a-Match Function, written in JavaScript version ES6+, accepts the input of two datasets (one dataset defining eligibility criteria for research studies or clinical decision support, and one dataset defining characteristics for an individual patient). It returns an output signaling whether the patient characteristics are a match for the eligibility criteria.

Purpose

Ultimately, such a system will play a “matchmaker” role in facilitating point-of-care recognition of patient-specific clinical decision support.

Specifications

The eligibility criteria are defined in HL7 FHIR (version R5) EvidenceVariable Resource JSON structure. The patient characteristics are provided in an FHIR Bundle Resource JSON including one Patient Resource and one or more Observation and Condition Resources which could be obtained from the patient's electronic health record.

Application

The Strike-a-Match Function determines whether or not the patient is a match to the eligibility criteria and an Eligibility Criteria Matching Software Demonstration interface provides a human-readable display of matching results by criteria for the clinician or patient to consider. This is the first software application, serving as proof of principle, that compares patient characteristics and eligibility criteria with all data exchanged using HL7 FHIR JSON. An Eligibility Criteria Matching Software Library at https://fevir.net/110192 provides a method for sharing functions using the same information model.

输入和输出:Strike-a-Match函数用JavaScript版本ES6+编写,接受两个数据集的输入(一个数据集定义研究或临床决策支持的资格标准,另一个数据集定义单个患者的特征)。它返回一个输出,表示患者的特征是否符合资格标准。目的:最终,这样的系统将发挥“媒人”的作用,促进护理点识别患者特定的临床决策支持。规范:资格标准在HL7 FHIR(版本R5)证据变量资源JSON结构中定义。患者特征在FHIR Bundle Resource JSON中提供,包括一个患者资源和一个或多个观察和条件资源,这些资源可以从患者的电子健康记录中获得。应用:Strike-a-Match功能确定患者是否符合资格标准,资格标准匹配软件演示界面提供了一个人类可读的显示匹配结果的标准,供临床医生或患者考虑。这是第一个软件应用程序,作为原理证明,将患者特征和资格标准与使用HL7 FHIR JSON交换的所有数据进行比较。https://fevir.net/110192上的资格标准匹配软件库提供了使用相同信息模型共享功能的方法。
{"title":"Striking a match between FHIR-based patient data and FHIR-based eligibility criteria","authors":"Brian S. Alper,&nbsp;Joanne Dehnbostel,&nbsp;Khalid Shahin,&nbsp;Neeraj Ojha,&nbsp;Gopal Khanna,&nbsp;Christopher J. Tignanelli","doi":"10.1002/lrh2.10368","DOIUrl":"10.1002/lrh2.10368","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Inputs and Outputs</h3>\u0000 \u0000 <p>The Strike-a-Match Function, written in JavaScript version ES6+, accepts the input of two datasets (one dataset defining eligibility criteria for research studies or clinical decision support, and one dataset defining characteristics for an individual patient). It returns an output signaling whether the patient characteristics are a match for the eligibility criteria.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Purpose</h3>\u0000 \u0000 <p>Ultimately, such a system will play a “matchmaker” role in facilitating point-of-care recognition of patient-specific clinical decision support.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Specifications</h3>\u0000 \u0000 <p>The eligibility criteria are defined in HL7 FHIR (version R5) EvidenceVariable Resource JSON structure. The patient characteristics are provided in an FHIR Bundle Resource JSON including one Patient Resource and one or more Observation and Condition Resources which could be obtained from the patient's electronic health record.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Application</h3>\u0000 \u0000 <p>The Strike-a-Match Function determines whether or not the patient is a match to the eligibility criteria and an Eligibility Criteria Matching Software Demonstration interface provides a human-readable display of matching results by criteria for the clinician or patient to consider. This is the first software application, serving as proof of principle, that compares patient characteristics and eligibility criteria with all data exchanged using HL7 FHIR JSON. An Eligibility Criteria Matching Software Library at https://fevir.net/110192 provides a method for sharing functions using the same information model.</p>\u0000 </section>\u0000 </div>","PeriodicalId":43916,"journal":{"name":"Learning Health Systems","volume":"7 4","pages":""},"PeriodicalIF":3.1,"publicationDate":"2023-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/lrh2.10368","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46565388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Toward a common standard for data and specimen provenance in life sciences 迈向生命科学中数据和标本来源的共同标准
IF 3.1 Q2 HEALTH POLICY & SERVICES Pub Date : 2023-04-18 DOI: 10.1002/lrh2.10365
Rudolf Wittner, Petr Holub, Cecilia Mascia, Francesca Frexia, Heimo Müller, Markus Plass, Clare Allocca, Fay Betsou, Tony Burdett, Ibon Cancio, Adriane Chapman, Martin Chapman, Mélanie Courtot, Vasa Curcin, Johann Eder, Mark Elliot, Katrina Exter, Carole Goble, Martin Golebiewski, Bron Kisler, Andreas Kremer, Simone Leo, Sheng Lin-Gibson, Anna Marsano, Marco Mattavelli, Josh Moore, Hiroki Nakae, Isabelle Perseil, Ayat Salman, James Sluka, Stian Soiland-Reyes, Caterina Strambio-De-Castillia, Michael Sussman, Jason R. Swedlow, Kurt Zatloukal, Jörg Geiger

Open and practical exchange, dissemination, and reuse of specimens and data have become a fundamental requirement for life sciences research. The quality of the data obtained and thus the findings and knowledge derived is thus significantly influenced by the quality of the samples, the experimental methods, and the data analysis. Therefore, a comprehensive and precise documentation of the pre-analytical conditions, the analytical procedures, and the data processing are essential to be able to assess the validity of the research results. With the increasing importance of the exchange, reuse, and sharing of data and samples, procedures are required that enable cross-organizational documentation, traceability, and non-repudiation. At present, this information on the provenance of samples and data is mostly either sparse, incomplete, or incoherent. Since there is no uniform framework, this information is usually only provided within the organization and not interoperably. At the same time, the collection and sharing of biological and environmental specimens increasingly require definition and documentation of benefit sharing and compliance to regulatory requirements rather than consideration of pure scientific needs. In this publication, we present an ongoing standardization effort to provide trustworthy machine-actionable documentation of the data lineage and specimens. We would like to invite experts from the biotechnology and biomedical fields to further contribute to the standard.

标本和数据的公开、实用的交流、传播和再利用已成为生命科学研究的基本要求。因此,所获得的数据的质量以及由此得出的结论和知识受到样本质量、实验方法和数据分析的显著影响。因此,分析前条件、分析程序和数据处理的全面和精确的文件对于能够评估研究结果的有效性至关重要。随着数据和样本的交换、重用和共享的重要性日益增加,需要实现跨组织文档、可追溯性和不可否认性的过程。目前,这些关于样本和数据来源的信息大多是稀疏的、不完整的或不连贯的。由于没有统一的框架,这些信息通常只在组织内部提供,不能互操作。与此同时,生物和环境标本的收集和分享越来越需要定义和记录利益分享和遵守管理要求,而不是单纯考虑科学需要。在本出版物中,我们提出了一项正在进行的标准化工作,以提供可信的数据谱系和样本的机器可操作文档。我们希望邀请生物技术和生物医学领域的专家进一步为标准做出贡献。
{"title":"Toward a common standard for data and specimen provenance in life sciences","authors":"Rudolf Wittner,&nbsp;Petr Holub,&nbsp;Cecilia Mascia,&nbsp;Francesca Frexia,&nbsp;Heimo Müller,&nbsp;Markus Plass,&nbsp;Clare Allocca,&nbsp;Fay Betsou,&nbsp;Tony Burdett,&nbsp;Ibon Cancio,&nbsp;Adriane Chapman,&nbsp;Martin Chapman,&nbsp;Mélanie Courtot,&nbsp;Vasa Curcin,&nbsp;Johann Eder,&nbsp;Mark Elliot,&nbsp;Katrina Exter,&nbsp;Carole Goble,&nbsp;Martin Golebiewski,&nbsp;Bron Kisler,&nbsp;Andreas Kremer,&nbsp;Simone Leo,&nbsp;Sheng Lin-Gibson,&nbsp;Anna Marsano,&nbsp;Marco Mattavelli,&nbsp;Josh Moore,&nbsp;Hiroki Nakae,&nbsp;Isabelle Perseil,&nbsp;Ayat Salman,&nbsp;James Sluka,&nbsp;Stian Soiland-Reyes,&nbsp;Caterina Strambio-De-Castillia,&nbsp;Michael Sussman,&nbsp;Jason R. Swedlow,&nbsp;Kurt Zatloukal,&nbsp;Jörg Geiger","doi":"10.1002/lrh2.10365","DOIUrl":"10.1002/lrh2.10365","url":null,"abstract":"<p>Open and practical exchange, dissemination, and reuse of specimens and data have become a fundamental requirement for life sciences research. The quality of the data obtained and thus the findings and knowledge derived is thus significantly influenced by the quality of the samples, the experimental methods, and the data analysis. Therefore, a comprehensive and precise documentation of the pre-analytical conditions, the analytical procedures, and the data processing are essential to be able to assess the validity of the research results. With the increasing importance of the exchange, reuse, and sharing of data and samples, procedures are required that enable cross-organizational documentation, traceability, and non-repudiation. At present, this information on the provenance of samples and data is mostly either sparse, incomplete, or incoherent. Since there is no uniform framework, this information is usually only provided within the organization and not interoperably. At the same time, the collection and sharing of biological and environmental specimens increasingly require definition and documentation of benefit sharing and compliance to regulatory requirements rather than consideration of pure scientific needs. In this publication, we present an ongoing standardization effort to provide trustworthy machine-actionable documentation of the data lineage and specimens. We would like to invite experts from the biotechnology and biomedical fields to further contribute to the standard.</p>","PeriodicalId":43916,"journal":{"name":"Learning Health Systems","volume":"8 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2023-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/lrh2.10365","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48771547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Learning Health Systems
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1